Dr Reddy's launches Finrid in India

Dr Reddy's Laboratories Ltd has launched Finrid (Fentanyl Transdermal Patch) in India. Used in the management of severe to moderate pain, Finrid provides continuous systemic delivery of Fentanyl, a potent opioid analgesic for upto 72 hours. It is the first opioid transdermal patch to be developed in India. 

Being a controlled substance, Finrid will be sold through an independent distribution structure and will be available across hospitals and palliative care centres in India, a company release stated.

Finrid is available in a transdermal patch form, and delivers dosages of 25 mcg/hr and 50 mcg/hr depending on the patch used.


Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying